ORTC Ortec International Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ORTC Ortec International

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jake who wrote (95)	3/16/1998 10:53:00 PM
From: fut_trade	Read Replies (2) of 272

I like to see insider buying. I think the buying is actually well coordinated effort to build up cash reserves, which Ortec will need to execute their business strategy. My feeling is that without JS and GS, those Class A warrants would never have been exercised. Same thing goes for the Class B warrants -- which have an exercise price of $15. The buying needs to continue so that the warrants will eventually be exercised. Ortec seems to be nearly finished with the clinical trials for using CCS for the treatment of non-healing skin ulcers of patients with EB. Do you know anything more about this -- regarding the FDA approval process? Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next